Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
7.06
-0.14 (-1.88%)
Nov 20, 2026, 11:22 AM EST - Market open
MRVI Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, MRVI stock has a consensus rating of "Buy" and an average price target of $9.64. The average 1-year stock price forecast is 36.68% higher than the current stock price, while the lowest is $8.00 (+13.39%) and the highest is $12 (+70.09%).
Price Target: $9.64 (+36.68%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for MRVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 5 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 3 | 3 | 3 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| KeyBanc | KeyBanc | Buy Upgrades $11 | Buy | Upgrades | $11 | +55.92% | Nov 12, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains $7 → $10 | Buy | Maintains | $7 → $10 | +41.74% | Nov 5, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $8 → $9.5 | Buy | Maintains | $8 → $9.5 | +34.66% | Nov 5, 2026 |
| TD Cowen | TD Cowen | Buy Initiates $9 | Buy | Initiates | $9 | +27.57% | Oct 5, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Initiates $2.5 → $8 | Hold | Initiates | $2.5 → $8 | +13.39% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
214.30M
from 185.74M
Increased by 15.38%
Revenue Next Year
224.56M
from 214.30M
Increased by 4.79%
EPS This Year
-0.07
from -0.29
EPS Next Year
-0.08
from -0.07
EPS and Forward PE are based on non-GAAP adjusted numbers.